Well the much anticipated drug has gotten FDA approval. This will certainly give me something to talk to the neuro about in February. I’m sure we’ll stick with my current Rebif therapy until Tysabri has a year or so on the market – or I start to get worse again. Plus I need time to convince the insurance company to cover both drugs. My one question if why the heck did they change the name to one that I can’t even begin to figure out how to pronounce! Here is the press release from Elan: FDA Grants Accelerated Approval of TYSABRI. Of course Serono had previously already raised some issues with the release of Antegren/Tysabri: Promising Antegren data ruffles Serono. I agree that two years worth of data isn’t much to go on but it was enough to get Rebif approved. I’m definitely of the mind set of wait and see both on efficacy and on safety – I’m not in the market to be a guinea pig. I am amused that this is produced by mice and Rebif is produced by hamster ovaries – will all the treatments come from the rodent family?!?